SHEZF (Shenzhen Hepalink Pharmaceutical Group Co) Other Current Liabilities: $36.8 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHEZF Shenzhen Hepalink Pharmaceutical Group Co Ltd SHEZF
65 GF Score
Price $0.47
GF Value $0.54
! 7 Warning Signs
View Full Analysis

What is Shenzhen Hepalink Pharmaceutical Group Co Other Current Liabilities?

Shenzhen Hepalink Pharmaceutical Group Co SHEZF 65 Other Current Liabilities is $36.8 Mil as of Mar. 2026. GuruFocus rates SHEZF with a GF Score™ of 65/100 and a GF Value™ of $0.54. The stock has 7 warning signs investors should review.

Shenzhen Hepalink Pharmaceutical Group Co's other current liabilities for the quarter that ended in Mar. 2026 was $36.8 Mil.

Shenzhen Hepalink Pharmaceutical Group Co's quarterly other current liabilities increased from Sep. 2025 ($30.3 Mil) to Dec. 2025 ($36.5 Mil) and increased from Dec. 2025 ($36.5 Mil) to Mar. 2026 ($36.8 Mil).

Shenzhen Hepalink Pharmaceutical Group Co's annual other current liabilities declined from Dec. 2023 ($51.3 Mil) to Dec. 2024 ($36.3 Mil) but then increased from Dec. 2024 ($36.3 Mil) to Dec. 2025 ($36.5 Mil).

Shenzhen Hepalink Pharmaceutical Group Co Other Current Liabilities Related Terms

Shenzhen Hepalink Pharmaceutical Group Co Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Shenzhen Hepalink Pharmaceutical Group Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen Hepalink Pharmaceutical Group Co Other Current Liabilities Chart

Shenzhen Hepalink Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 60.85 62.23 51.34 36.30 36.49

Shenzhen Hepalink Pharmaceutical Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.94 29.46 30.34 36.49 36.76
SHEZF
65GF Score
Shenzhen Hepalink Pharmaceutical Group Co Ltd SHEZF
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shenzhen Hepalink Pharmaceutical Group Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $36.8 Mil mean?
Shenzhen Hepalink Pharmaceutical Group Co (SHEZF) has a Other Current Liabilities of $36.8 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Shenzhen Hepalink Pharmaceutical Group Co.
Is Shenzhen Hepalink Pharmaceutical Group Co's Other Current Liabilities too high?
Shenzhen Hepalink Pharmaceutical Group Co's current Other Current Liabilities is $36.8 Mil. Overall, Shenzhen Hepalink Pharmaceutical Group Co has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Hepalink Pharmaceutical Group Co's Other Current Liabilities compare to ZTS and UTHR?
Shenzhen Hepalink Pharmaceutical Group Co's Other Current Liabilities of $36.8 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Shenzhen Hepalink Pharmaceutical Group Co. Shenzhen Hepalink Pharmaceutical Group Co's current Other Current Liabilities is $36.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Hepalink Pharmaceutical Group Co stock overvalued right now?
Shenzhen Hepalink Pharmaceutical Group Co (SHEZF) has a current Other Current Liabilities of $36.8 Mil. The stock's GF Value™ is $0.54, compared to a current price of $0.47 — trading 13% below its estimated fair value. The current Other Current Liabilities is $36.8 Mil. Shenzhen Hepalink Pharmaceutical Group Co's overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Shenzhen Hepalink Pharmaceutical Group Co (SHEZF), the current Other Current Liabilities is $36.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shenzhen Hepalink Pharmaceutical Group Co (SHEZF) Overvalued in 2026?

Based on GuruFocus' analysis, Shenzhen Hepalink Pharmaceutical Group Co stock appears to be undervalued. The current stock price of $0.47 is trading 13% below its estimated GF Value™ of $0.54.

Key valuation signals for SHEZF:

  • Other Current Liabilities: $36.8 Mil
  • GF Value™: $0.54 vs. price of $0.47 (13% below fair value)
  • GF Score™: 65/100 with 7 warning signs

No single metric tells the full story. See the SHEZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shenzhen Hepalink Pharmaceutical Group Co Business Description

Other Exchanges 09989:Hong Kong002399:China
Address No. 21 Langshan Road, Songping Mountain, Guangdong Province, Nanshan District, Shenzhen, CHN, 518057
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company. Along with its subsidiary, it is engaged in biopharmaceutical production, biopharmaceutical services, biopharmaceutical trading, and biopharmaceutical research and development in Asia, Europe, North America, and Australia, and investment business in Asia and North America. The Group mainly operates three main business segments, including the Finished dose pharmaceutical products; Active pharmaceutical ingredients; CDMO business; and Others. The geographical presence of the company is in Hong Kong, the United States of America, Europe, Mainland China, and Other countries. The majority of the company's revenue comes from Europe and the USA.
65GF Score

Get the complete analysis for SHEZF

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.47
Price
$0.54
GF Value